complement
system
function
immun
surveil
system
rapidli
respond
infect
activ
complement
system
specif
recognit
pathway
trigger
proteas
cascad
gener
cleavag
product
function
elimin
pathogen
regul
inflammatori
respons
shape
adapt
immun
respons
howev
dysregul
power
function
becom
destruct
complement
system
implic
pathogen
effector
numer
diseas
includ
infecti
diseas
review
highlight
recent
discoveri
identifi
critic
role
complement
system
pathogenesi
viral
infect
identifi
interact
ctype
lectin
express
macrophag
kang
et
al
activ
thrombin
huberlang
et
al
properdinactiv
pathway
kemper
et
al
classic
pathway
primarili
activ
igm
certain
igg
isotyp
bound
antigen
immun
complex
interact
complement
compon
bind
lead
activ
two
serin
proteas
associ
cleav
result
exposur
reactiv
thioester
allow
coval
attach
surfac
bind
also
cleav
form
classic
pathway
convertas
convertas
cleav
amplifi
complement
activ
lead
gener
ligand
varieti
complement
receptor
lectin
pathway
initi
pattern
recognit
receptor
mannosebind
lectin
mbl
ficolin
fig
mbl
ficolin
contain
carbohydraterecognit
domain
recogn
carbohydr
pattern
surfac
cell
invad
microorgan
mbl
ficolin
complex
enzym
known
mblassoci
serin
proteas
masp
similar
activ
complement
system
cleav
form
convertas
altern
pathway
activ
spontan
hydrolysi
fig
pathway
also
function
amplif
loop
cleavag
initi
trigger
mechan
bound
target
surfac
bound
proteas
factor
b
fb
factor
fd
serin
proteas
cleav
fb
result
gener
bb
format
altern
pathway
convertas
classic
altern
convertas
function
cleav
similar
cleavag
expos
reactiv
thioester
bond
allow
coval
attach
target
surfac
addit
bind
either
classic
altern
convertas
result
chang
substrat
specif
convertas
convertas
cleav
releas
promot
assembl
membran
attack
complex
mac
directli
lyse
pathogen
pathogeninfect
cell
anaphylatoxin
interact
specif
receptor
promot
chemotaxi
regul
effector
function
cell
innat
adapt
immun
respons
varieti
solubl
membraneassoci
protein
regul
complement
activ
factor
h
fh
protein
inhibitor
solubl
protein
regul
activ
complement
system
fh
promot
dissoci
convertas
act
cofactor
factor
fi
mediat
cleavag
function
similar
fh
promot
dissoci
convertas
act
cofactor
fimedi
cleavag
serin
proteas
inhibitor
inactiv
proteas
classic
pathway
well
masp
lectin
pathway
membraneassoci
regul
complement
activ
includ
decay
acceler
factor
membran
cofactor
protein
complement
receptor
crri
rodentspecif
protein
function
destabil
classic
altern
complement
convertas
act
cofactor
fimedi
cleavag
prevent
assembl
mac
cell
surfac
complement
system
increasingli
recogn
mediat
protect
patholog
varieti
viral
infect
furthermor
continu
identif
novel
mechan
viral
antagon
complement
highlight
import
role
system
viral
pathogenesi
review
recent
studi
viral
interact
varieti
compon
complement
system
emphas
fig
schemat
complement
system
complement
activ
three
major
pathway
classic
pathway
primarili
activ
interact
igm
certain
igg
isotyp
bound
antigen
cleav
form
classic
pathway
cp
convertas
lectin
pathway
lp
initi
carbohydr
pattern
recognit
receptor
mannosebind
lectin
mbl
ficolin
f
complex
enzym
known
mblassoci
serin
proteas
masp
activ
complement
system
cleav
form
convertas
altern
pathway
ap
activ
spontan
hydrolysi
pathway
also
function
amplif
loop
cleavag
initi
trigger
mechan
bound
target
surfac
bound
proteas
factor
b
fb
factor
fd
serin
proteas
cleav
fb
result
gener
bb
format
altern
pathway
convertas
classic
altern
convertas
function
cleav
cleavag
expos
reactiv
thioester
bond
allow
coval
attach
target
surfac
addit
bind
either
classic
altern
convertas
result
chang
substrat
specif
convertas
convertas
cleav
releas
promot
assembl
membran
attack
complex
mac
directli
lyse
pathogen
pathogeninfect
cell
cleav
factor
fi
function
enhanc
factor
h
fh
gener
degrad
product
degrad
product
interact
cellular
receptor
regul
effector
function
phagocytosi
b
cell
activ
anaphylatoxin
interact
specif
receptor
promot
chemotaxi
regul
effector
function
cell
innat
adapt
immun
respons
find
describ
interact
impact
develop
virusinduc
diseas
perhap
best
evid
complement
import
role
outcom
viru
infect
identif
specif
mechan
evolv
virus
evad
complement
system
fig
one
mechan
employ
virus
directli
encod
protein
structur
function
homolog
host
protein
function
regul
complement
activ
gammaherpesvirus
includ
kaposi
sarcomaassoci
herpesviru
herpesviru
saimiri
murin
encod
homolog
complement
regulatori
protein
albrecht
fleckenstein
mullick
et
al
spiller
et
al
virgin
et
al
regul
complement
activ
rca
protein
express
surfac
infect
cell
detect
supernat
cell
thu
membraneassoci
solubl
form
kapadia
et
al
recombin
rca
protein
supernat
cell
block
deposit
zymosan
exampl
viral
evas
complement
system
viral
encod
protein
allow
virus
evad
complementmedi
destruct
human
astroviru
hastv
coat
protein
cp
bind
mbl
inhibit
activ
lectin
classic
pathway
influenza
matrix
protein
also
bind
flaviviru
nonstructur
protein
bind
lead
enhanc
cleavag
well
factor
h
fh
lead
increas
cofactor
activ
fh
factor
fi
mediat
cleavag
addit
membranebound
flaviviru
decreas
deposit
mac
cell
surfac
murin
regul
complement
protein
rca
block
deposit
wherea
glycoprotein
gc
bind
block
bind
properdin
variola
viru
inhibitor
complement
enzym
spice
vaccinia
viru
complement
control
protein
vcp
monkeypox
viru
inhibitor
complement
enzym
mopic
ectromelia
viru
inhibitor
complement
enzym
emic
function
cofactor
fimedi
cleavag
bind
virus
correspond
protein
interfer
complement
cascad
parenthes
indic
red
b
virus
recruit
host
complement
regulatori
protein
virion
human
immunodefici
human
tlymphotrop
human
cytomegaloviru
hcmv
incorpor
host
complement
control
protein
virion
simian
viru
mump
viru
muv
recruit
virion
physiolog
complement
regulatori
protein
shown
green
virus
incorpor
regulatori
protein
virion
indic
red
bead
classic
altern
activ
pathway
kapadia
et
al
directli
test
role
rca
protein
pathogenesi
kapadia
et
al
gener
delet
rca
protein
evalu
outcom
infect
wildtyp
mice
kapadia
et
al
delet
rca
protein
result
decreas
virul
follow
intracrani
inocul
weanl
mice
intraperiton
inocul
adult
mice
model
acut
meningoenceph
persist
infect
respect
genet
delet
host
abl
restor
virul
rca
proteindelet
viru
model
acut
meningoenceph
enhanc
persist
replic
confirm
rca
protein
interact
host
complement
system
critic
regul
pathogenesi
interestingli
although
wildtyp
mice
reduc
number
latent
infect
cell
compar
mice
indic
complement
regul
establish
latent
infect
effect
counteract
rca
protein
kapadia
et
al
poxvirus
variola
viru
vaccinia
viru
monkeypox
viru
ectromelia
viru
also
encod
complement
regulatori
protein
structur
function
homolog
host
encod
regul
complement
pathway
mullick
et
al
fig
variola
viru
inhibitor
complement
enzym
spice
vaccinia
viru
complement
control
protein
vcp
monkeypox
viru
inhibitor
complement
enzym
mopic
ectromelia
viru
inhibitor
complement
enzym
emic
bind
well
function
cofactor
fimedi
cleavag
moulton
et
al
rosengard
et
al
sahu
et
al
vcpdelet
vaccinia
viru
produc
smaller
skin
lesion
rabbit
compar
wildtyp
vaccinia
viru
isaac
et
al
pathogenesi
studi
cynomolgu
monkey
differ
strain
monkeypox
viru
reveal
mopic
delet
less
virul
strain
chen
et
al
furthermor
spice
much
potent
inhibitor
human
complement
compar
vcp
mopic
correl
increas
virul
variola
viru
human
compar
vaccinia
viru
monkeypox
viru
rosengard
et
al
taken
togeth
studi
find
multipl
compon
complement
pathway
requir
mice
surviv
ectromelia
viru
infect
discuss
indic
complement
activ
viral
evas
complement
system
critic
determin
poxviru
pathogenesi
contrast
herpesvirus
poxvirus
flavivirus
encod
protein
antagon
complement
system
despit
lack
sequenc
homolog
known
regul
complement
system
nonstructur
protein
encod
flavivirus
glycosyl
protein
detect
within
infect
cell
cell
surfac
secret
infect
cell
alconlepod
et
al
accumul
serum
dengu
virusinfect
individu
high
circul
level
associ
sever
diseas
avirutnan
et
al
librati
et
al
attempt
purifi
wnv
cell
supernat
chung
et
al
observ
fh
copurifi
chung
et
al
solubl
wnv
found
enhanc
cofactor
activ
fh
fimedi
cleavag
cell
surfaceassoci
decreas
deposit
membran
attack
complex
cell
surfac
fig
flaviviru
also
bind
avirutnan
et
al
fig
activ
enhanc
cleavag
result
reduc
activ
classic
convertas
reduc
deposit
cell
surfac
avirutnan
et
al
provid
addit
mechan
flavivirus
evad
complementdepend
neutral
solubl
also
report
bind
complement
inhibitori
factor
clusterin
normal
inhibit
format
membran
attack
complex
kurosu
et
al
howev
function
consequ
interact
report
mani
virus
employ
similar
complement
evas
strategi
encod
protein
bind
inhibit
sequest
complement
compon
exampl
coat
protein
human
astroviru
type
suppress
complement
activ
bind
function
displac
proteas
tetram
thu
inhibit
classic
pathway
activ
bonapart
et
al
hair
et
al
fig
demonstr
serotyp
bonapart
et
al
astroviru
coat
protein
also
bound
mbl
inhibit
mannanmedi
activ
lectin
pathway
hair
et
al
discuss
enhanc
neutral
hemagglutin
inhibit
activ
antiinfluenza
antibodi
experiment
evid
suggest
matrix
protein
influenza
viru
evolv
counteract
host
respons
prevent
complementmedi
neutral
influenza
viru
vitro
bind
block
interact
igg
zhang
et
al
herp
simplex
viru
encod
sever
immun
modul
includ
glycoprotein
c
gc
inhibit
activ
complement
cascad
bind
fragment
friedman
et
al
fri
et
al
kostavasili
et
al
talsing
et
al
block
bind
properdin
fri
et
al
hung
et
al
kostavasili
et
al
effect
mediat
two
distinct
domain
gc
one
domain
block
properdin
bind
directli
bind
fragment
hung
et
al
vitro
gc
protect
hsvinfect
cell
complementmedi
lysi
harri
et
al
cellfre
viru
complementmedi
neutral
friedman
et
al
hidaka
et
al
demonstr
natur
igm
antibodi
bind
neutral
gcnull
virus
via
mechan
hook
et
al
studi
anim
model
confirm
import
gcmediat
complement
inhibit
pathogenesi
inocul
intravagin
wildtyp
guinea
pig
guinea
pig
gcnull
replic
less
effici
caus
significantli
less
sever
vagin
compar
wildtyp
lubinski
et
al
attenu
phenotyp
gcnull
confirm
inocul
wildtyp
mice
via
skin
scratch
evalu
zosteriform
diseas
lubinski
et
al
lubinski
et
al
studi
murin
model
demonstr
domain
gc
modul
complement
activ
critic
virul
factor
howev
specif
lack
bind
domain
attenu
compar
specif
lack
properdin
inhibitori
domain
lubinski
et
al
importantli
gc
mutant
virus
virul
wildtyp
viru
mice
indic
gc
interact
complement
system
regul
pathogenesi
lubinski
et
al
recent
knowledg
gain
studi
util
improv
vaccin
efficaci
infect
awasthi
colleagu
demonstr
combin
immun
glycoprotein
gd
potent
immunogen
gc
prevent
evas
complement
due
develop
antigc
antibodi
respons
enhanc
protect
provid
gd
immun
awasthi
et
al
number
virus
evad
complement
system
recruit
host
complement
regulatori
protein
virion
fig
instanc
human
immunodefici
human
tlymphotrop
human
cytomegaloviru
hcmv
incorpor
complement
control
protein
virion
thu
protect
virion
complementmedi
destruct
spear
et
al
simian
viru
mump
viru
muv
paramyxovirus
neutral
manner
result
virion
aggreg
virion
lysi
respect
johnson
et
al
studi
reveal
muv
virion
contain
membraneassoci
protein
cofactor
activ
fimedi
cleavag
incorpor
muv
confer
virionassoci
cofactor
activ
increas
resist
muv
complementdepend
neutral
thu
virus
evolv
usurp
host
complement
regulatori
protein
avoid
complementmedi
destruct
mannos
bind
lectin
mbl
ctype
lectin
play
import
role
innat
immun
bind
carbohydr
wide
rang
pathogen
fujita
recognit
carbohydr
mediat
via
ctermin
carbohydr
recognit
domain
bound
mbl
activ
complement
due
associ
masp
act
directli
opsonin
polymorph
promot
structur
region
human
gene
affect
mbl
oligom
format
circul
level
protein
madsen
et
al
due
differ
mutat
human
exhibit
variat
circul
mbl
level
occur
vari
frequenc
differ
popul
recent
number
studi
demonstr
direct
interact
mbl
viru
particl
neutral
infect
mbl
found
bind
directli
virion
number
differ
viru
famili
includ
human
immunodefici
viru
hiv
sever
acut
respiratori
syndrom
coronaviru
sarscov
ebola
viru
dengu
viru
denv
west
nile
viru
wnv
fig
find
hiv
envelop
glycoprotein
modifi
high
mannos
oligosaccharid
led
research
test
potenti
hiv
function
ligand
mbl
mbl
shown
bind
directli
hivinfect
cell
recombin
ezekowitz
et
al
import
interact
demonstr
experi
show
mbl
could
inhibit
infect
specif
target
cell
cell
culturederiv
hiv
although
primari
isol
hiv
bound
mbl
saifuddin
et
al
mbl
bind
ineffici
inhibit
infect
peripher
blood
mononuclear
cell
ying
et
al
howev
mbl
bind
lead
effici
opson
uptak
hiv
mononuclear
phagocyt
ying
et
al
despit
find
role
mbl
hiv
pathogenesi
still
unclear
differ
studi
investig
associ
mbl
level
hiv
infect
found
associ
increas
suscept
among
individu
low
mbl
level
increas
suscept
among
individu
high
mbl
level
ji
et
al
howev
area
research
led
effort
identifi
lectin
interact
hiv
inhibit
infect
novel
therapeut
approach
prevent
hiv
infect
diseas
alexandr
et
al
hoorelbek
et
al
husken
et
al
mbl
also
report
bind
sarscov
retrovir
particl
pseudotyp
sarscov
spike
glycoprotein
sarss
ip
et
al
zhou
et
al
fig
similarli
mbl
bind
effici
retrovir
particl
pseudotyp
ebola
viru
marburg
viru
glycoprotein
ji
et
al
fig
importantli
studi
show
direct
mblmediat
neutral
viru
infect
ip
et
al
ji
et
al
mbl
bind
sarss
depend
singl
nlink
glycosyl
site
sarss
zhou
et
al
mbl
bind
block
interact
sarss
dcsign
previous
identifi
interact
sarss
yang
et
al
major
sarscov
receptor
angiotensinconvert
enzym
li
et
al
serum
level
mbl
report
significantli
lower
patient
sar
control
patient
howev
associ
mbl
genotyp
mortal
relat
sar
ip
et
al
second
studi
also
report
mbl
gene
polymorph
associ
reduc
mbl
level
significantli
associ
suscept
sarscov
infect
zhang
et
al
howev
third
studi
report
mbl
genotyp
allel
frequenc
influenc
outcom
infect
sarscov
yuan
et
al
final
studi
show
mbl
bind
nlink
glycan
structur
protein
wnv
denv
result
neutral
mechan
occur
part
block
viral
fusion
find
indic
mbl
opson
suffici
neutral
rather
deposit
onto
virion
also
requir
wnv
neutral
occur
viru
produc
insect
cell
denv
neutral
occur
insect
mammalian
cellderiv
viru
experi
mice
demonstr
acceler
intravascular
clearanc
denv
wnv
mutant
two
nlink
glycan
e
protein
wildtyp
wnv
mbldepend
complement
system
enhanc
humor
immun
number
differ
mechan
complement
regul
effector
function
natur
immun
antibodi
complement
compon
receptor
particip
captur
transport
antigen
b
cell
compart
secondari
lymphoid
tissu
gonzalez
et
al
complement
receptor
complement
receptor
express
follicular
dendrit
cell
function
retain
antigen
lymphoid
follicl
requir
gener
normal
humor
immun
respons
fang
et
al
b
lymphocyt
form
complex
protein
activ
signal
transduct
pathway
regul
b
cell
activ
colig
b
cell
receptor
bind
cleavag
product
coval
attach
antigen
lower
threshold
b
cell
activ
bradburi
et
al
hebel
et
al
heyman
et
al
fact
link
model
antigen
gener
fusion
protein
fold
immunogen
dempsey
et
al
numer
studi
establish
critic
role
complement
system
regul
humor
immun
viru
infect
highlight
recent
find
particular
emphasi
studi
investig
pathway
context
viral
pathogenesi
natur
antibodi
complement
neutral
viru
humor
immun
individu
consist
primarili
natur
igm
antibodi
ochsenbein
zinkernagel
natur
igm
polyreact
thought
endogen
antigen
drive
gener
natur
igm
igm
exist
circul
primarili
pentam
greater
bind
affin
compar
igg
make
potent
activ
complement
system
ehrenstein
notley
initi
studi
reveal
presenc
natur
igm
specif
variou
viral
pathogen
includ
lymphocyt
choriomening
viru
lcmv
vesicular
stomat
viru
vsv
vaccinia
viru
vv
sera
mice
reconstitut
mice
sera
mice
research
demonstr
natur
antibodi
protect
mice
vsv
dissemin
diseas
ochsenbein
et
al
earlier
studi
shown
natur
igm
antibodi
vsv
antigen
form
immun
complex
activ
initi
complement
activ
via
classic
pathway
viral
surfac
thu
neutral
vsv
beeb
cooper
neutral
associ
deposit
viral
envelop
like
interfer
vsv
attach
suscept
cell
natur
igm
compon
classic
activ
pathway
also
shown
neutral
influenza
viru
jayasekera
et
al
interestingli
rather
result
lysi
virion
interact
result
coat
aggreg
viru
particl
test
signific
interact
influenza
pathogenesi
mice
reconstitut
natur
igm
challeng
mouseadapt
strain
influenza
reconstitut
prolong
mous
surviv
follow
influenza
challeng
suggest
natur
igm
complement
also
protect
host
influenza
infect
furthermor
complement
igm
requir
develop
protect
immun
influenza
viru
immun
fernandez
gonzalez
et
al
similar
influenza
viru
sera
mice
neutral
ectromelia
viru
mechan
depend
complement
natur
antibodi
moulton
et
al
analys
reveal
opson
ectromelia
viru
particl
primari
mediat
neutral
consist
find
ectromelia
viru
dissemin
effici
viral
load
tissu
greater
mice
defici
mortal
studi
genet
defici
complement
compon
fb
result
higher
mortal
rate
compar
wildtyp
mice
addit
reconstitut
b
celldefici
mice
sera
contain
natur
antibodi
significantli
increas
surviv
follow
inocul
ectromelia
viru
sum
studi
reveal
import
role
natur
antibodi
complement
protect
viru
infect
complementmedi
enhanc
b
lymphocyt
respons
protect
virusinduc
diseas
studi
humor
respons
herpesviru
infect
yield
import
insight
complementmedi
regul
b
cell
function
mice
defici
mice
encod
significantli
diminish
igg
respons
follow
herp
simplex
infect
suggest
activ
classic
pathway
play
key
role
regul
antibodi
respons
infect
da
costa
et
al
interestingli
mice
reconstitut
bone
marrow
wildtyp
mice
develop
normal
antibodi
respons
follow
infect
wildtyp
mice
reconstitut
bone
marrow
mice
significantli
diminish
igg
respons
verschoor
et
al
verschoor
et
al
experi
indic
deriv
bone
marrow
cell
essenti
enhanc
b
cell
activ
respons
infect
first
studi
describ
import
function
complement
factor
synthes
local
nonhepat
cellular
sourc
contrast
infect
igg
respons
vsv
infect
neurotrop
mice
caus
paralysi
death
similar
mice
compar
wildtyp
mice
ochsenbein
et
al
instead
research
discov
complement
compon
critic
initi
antivsv
igm
respons
experi
suggest
complement
critic
target
vsv
antigen
margin
zone
macrophag
lymphoid
tissu
stimul
b
cell
igm
product
mice
mice
suscept
lethal
vsv
infect
suggest
depress
igm
respons
critic
limit
vsv
spread
replic
central
nervou
system
unlik
vsv
infect
genet
absenc
result
increas
wnvinduc
mortal
earlier
wnv
entri
central
nervou
system
greater
viral
load
wnv
brain
mice
suggest
complementmedi
regul
b
cell
respons
critic
control
wnv
dissemin
replic
diseas
mehlhop
et
al
fact
requir
normal
antiwnv
igm
igg
respons
mice
passiv
transfer
immun
serum
protect
mice
lethal
wnv
infect
studi
antibodi
respons
wnv
found
normal
mice
defici
fb
fd
compon
altern
complement
activ
pathway
mehlhop
diamond
find
consist
previou
find
igg
respons
tdepend
antigen
normal
fb
mice
matsumoto
et
al
indic
compon
altern
complement
activ
pathway
requir
develop
antiwnv
antibodi
respons
contrast
compon
classic
lectin
complement
activ
pathway
requir
normal
humor
respons
wnv
infect
mehlhop
diamond
interestingli
requir
normal
antiwnv
igm
respons
wherea
requir
normal
antiwnv
igg
respons
find
suggest
distinct
complement
pathway
regul
igm
vs
igg
respons
least
context
viral
infect
importantli
similar
defici
mice
mice
much
suscept
lethal
wnvinfect
provid
evid
host
complement
system
critic
limit
sever
wnv
diseas
mehlhop
diamond
regul
antivir
antibodi
effector
mechan
number
recent
studi
identifi
critic
role
complement
particular
complement
compon
regul
antivir
antibodi
effector
mechan
research
investig
serumspecif
enhanc
influenza
viru
hemagglutinin
ha
specif
monoclon
antibodi
discov
could
enhanc
neutral
activ
hemagglutin
inhibit
hi
activ
feng
et
al
strongli
influenc
hi
activ
enhanc
requir
suggest
effect
independ
complement
activ
enhanc
hi
activ
neutral
activ
depend
antibodi
isotyp
epitop
specif
feng
et
al
mozdzanowska
et
al
antibodydepend
enhanc
ade
infect
describ
multipl
virus
case
dengu
virus
ade
associ
sever
diseas
balsiti
et
al
kyle
harri
zellweg
et
al
util
vitro
assay
design
measur
ade
dengu
viru
infect
research
discov
presenc
fresh
serum
could
complet
abolish
ade
mehlhop
et
al
yamanaka
et
al
analys
demonstr
inhibitori
effect
fresh
serum
ade
antibodi
isotypespecif
mehlhop
et
al
yamanaka
et
al
howev
separ
studi
suppress
ade
fresh
serum
found
thu
extent
complement
compon
particip
mediat
effect
unclear
addit
suppress
ade
shown
enhanc
neutral
activ
antiwnv
antibodi
mehlhop
et
al
mechanist
studi
reveal
reduc
number
antibodi
requir
bind
wnv
virion
neutral
infect
interestingli
reduc
number
antibodi
requir
neutral
level
minimum
number
requir
ade
importantli
abil
antiwnv
antibodi
protect
lethal
infect
decreas
mice
compar
wildtyp
mice
indic
enhanc
neutral
activ
regul
wnv
pathogenesi
contrast
effect
ade
flaviviru
infect
ade
ebola
zair
viru
infect
glycoprotein
reston
strain
ebola
viru
less
pathogen
human
induc
less
enhanc
activ
compar
zair
strain
suggest
ade
may
also
play
role
ebola
viru
pathogenesi
regul
cell
complement
system
increas
evid
variou
experiment
system
indic
complement
regul
cell
activ
effector
function
dunkelberg
song
kemper
atkinson
numer
complement
receptor
membran
complement
regulatori
protein
express
antigenpres
cell
apc
cell
engag
receptor
apc
regul
apc
effector
function
chemokin
cytokin
gene
express
modul
apc
function
influenc
cell
activ
antigen
present
direct
action
complement
cell
less
well
understood
ligat
cell
shown
inhibit
cell
prolifer
wagner
et
al
receptor
shown
regul
cell
traffick
tsuji
et
al
addit
sever
membran
complement
regulatori
protein
link
cell
regul
exampl
bind
serv
cofactor
proteolyt
inactiv
found
regul
prolifer
effector
function
cell
mari
et
al
critic
complement
regul
effector
function
activ
cell
regul
develop
helper
cell
exampl
mice
protect
airway
hypereact
link
decreas
cell
respons
enhanc
produc
helper
cell
drouin
et
al
lajoi
et
al
contrast
provid
protect
airway
hypereact
regul
cytokin
product
lajoi
et
al
final
evid
suggest
complement
also
regul
termin
cell
respons
induc
develop
regulatori
cell
kemper
et
al
util
mous
model
research
discov
requir
normal
cell
respons
influenza
viru
lymphocyt
choriomening
viru
lcmv
infect
friend
viru
fv
infect
banki
et
al
kopf
et
al
suresh
et
al
vitro
dendrit
cell
expos
complementopson
fv
hiv
better
induc
cell
activ
banki
et
al
effect
also
observ
complement
opson
fv
mice
furthermor
mice
reduc
number
fvspecif
cell
higher
number
infect
spleen
cell
compar
wildtyp
control
suggest
complementmedi
regul
cell
respons
function
control
fv
replic
banki
et
al
similarli
mice
defici
delay
clearanc
influenza
viru
increas
titer
lung
find
correl
dramat
decreas
recruit
virusspecif
cell
produc
lung
influenza
virusinfect
mice
follow
either
lcmv
influenza
viru
infect
requir
normal
prime
cell
mice
defici
mice
show
defect
indic
regul
cell
respons
manner
kopf
et
al
suresh
et
al
lcmvinfect
mice
effect
cell
prime
expans
epitopedepend
influenc
mous
genet
background
suggest
may
regul
epitop
select
subsequ
experi
indic
may
import
role
regul
cell
respons
influenza
viru
infect
treatment
mice
antagonist
reduc
number
influenza
virusspecif
cell
lung
lymphoid
tissu
kim
et
al
studi
util
mous
model
wnv
infect
diseas
identifi
distinct
complement
pathway
regul
antivir
cell
respons
mehlhop
diamond
mice
defici
fb
found
highli
suscept
lethal
wnv
infect
despit
normal
antiwnv
antibodi
respons
instead
fb
mice
mice
reduc
cell
respons
spleen
impair
traffick
cell
cn
similar
find
observ
wnvinocul
mice
suggest
lectin
altern
complement
activ
pathway
contribut
regul
cell
function
thu
similar
fv
influenza
viru
lcmv
infect
complement
activ
requir
normal
cell
prime
traffick
follow
wnv
infect
role
complement
regulatori
protein
regul
cell
respons
viral
infect
also
investig
mice
defici
decay
acceler
factor
daf
regul
format
inactiv
convertas
increas
expans
cell
greater
kill
capac
follow
lcmv
infect
correl
lower
viral
titer
enhanc
cell
respons
revers
mice
defici
daf
daf
contrast
follow
vaccinia
viru
infect
cell
respons
enhanc
mice
defici
block
format
membran
attack
complex
longhi
et
al
taken
togeth
studi
suggest
membran
complement
regul
regul
cell
immun
howev
cell
respons
follow
vaccinia
viru
infect
enhanc
mice
indic
effect
cell
respons
like
independ
complement
activ
least
follow
vaccinia
viru
infect
hepat
c
viru
hcv
appear
exploit
complement
system
establish
persist
hcv
core
protein
first
protein
express
earli
phase
hcv
infect
free
hcv
core
particl
found
blood
hcvinfect
patient
maillard
et
al
evalu
variou
vaccinia
viru
vv
hcv
recombin
mice
larg
et
al
discov
recombin
vv
express
hcv
core
protein
produc
lethal
infect
mice
suppress
vvspecif
cell
respons
larg
et
al
use
yeast
twohybrid
approach
kittlesen
colleagu
identifi
hcv
core
protein
bound
receptor
specif
globular
head
protein
kittlesen
et
al
fig
bind
hcv
core
protein
inhibit
human
peripher
blood
cell
prolifer
standard
oneway
mix
lymphocyt
reaction
mlr
follow
mitogen
stimul
kittlesen
et
al
similar
effect
bind
natur
ligand
suppress
revers
addit
anticor
antibodi
tcell
prolifer
assay
kittlesen
et
al
specif
bind
hcv
core
protein
activ
human
peripher
blood
cell
decreas
product
decreas
express
yao
et
al
recent
clinic
studi
investig
impact
hcv
infect
cell
respons
acut
compar
resolv
versu
chronic
infect
cum
et
al
acut
phase
hcv
infect
frequenc
cell
increas
compar
healthi
control
six
month
later
frequenc
cell
remain
elev
chronic
patient
compar
resolv
patient
chronic
patient
also
higher
level
circul
hcv
core
protein
tcr
stimul
increas
frequenc
cell
result
coreinduc
inhibit
cell
respons
resolv
chronic
patient
result
suggest
hcv
infect
expand
cell
increas
suscept
coremedi
immun
dysregul
cum
et
al
also
express
immun
cell
dendrit
cell
dc
b
cell
dc
isol
patient
chronic
infect
hcv
display
reduc
capac
induc
cell
activ
produc
cytokin
auffermanngretzing
et
al
bain
et
al
dolganiuc
et
al
kakumu
et
al
kanto
et
al
kanto
et
al
waggon
colleagu
demonstr
bind
hcv
core
protein
human
monocytederiv
dc
mddc
inhibit
tlrinduc
product
product
tlrinduc
cytokin
waggon
et
al
addit
hcv
core
protein
engag
mddc
promot
product
cytokin
cocultur
cell
result
suggest
engag
dc
hcv
core
limit
induct
respons
waggon
et
al
contrast
effect
cell
dc
hcv
core
protein
bind
b
cell
lead
b
cell
activ
prolifer
increas
costimulatori
chemokin
receptor
express
cell
prolifer
igm
igg
product
phosphoryl
downregul
express
yao
et
al
data
suggest
hcv
exploit
complement
system
dysregul
host
immun
respons
via
variou
mechan
order
establish
persist
investig
role
hcv
core
protein
hcv
pathogenesi
transgen
mice
develop
tetracyclineregul
condit
hcv
core
protein
express
chang
et
al
mice
develop
liver
inflamm
steatosi
fibrosi
microarray
analys
inflam
liver
show
induct
mani
compon
complement
coagul
pathway
administr
daf
decreas
hepat
inflamm
suggest
hcv
core
complement
system
contribut
hepat
inflamm
associ
hcv
infect
cryoglobulinemia
system
vascul
damag
small
mediums
arteri
vein
skin
kidney
peripher
nerv
dammacco
et
al
evid
suggest
deposit
immun
complex
vessel
wall
activ
complement
mediat
damag
mix
cryoglobulinemia
mc
involv
multipl
immunoglobulin
isotyp
observ
hepat
c
viru
hcv
infect
patient
associ
increas
durat
hcv
infect
charl
dustin
hcvposit
patient
mc
circul
nonenvelop
hcv
core
protein
detect
cryoprecipit
immun
complex
sansonno
et
al
discuss
hcv
core
protein
interact
proteolyt
cleav
releas
cell
surfac
kittlesen
et
al
studi
hcvposit
mc
patient
reveal
mc
follow
hcv
infect
correl
significantli
higher
level
circul
compar
hcvinfect
patient
without
mc
sansonno
et
al
addit
higher
serum
level
neg
correl
circul
level
fragment
instead
sequest
vascular
bed
skin
biopsi
mc
patient
indic
complement
activ
vascular
bed
sansonno
et
al
data
suggest
follow
hcv
infect
dysregul
shed
molecul
contribut
vascular
cryoglobulininduc
damag
via
complementmedi
pathway
sansonno
et
al
hcv
also
link
pulmonari
diseas
asthma
chronic
obstruct
pulmonari
diseas
copd
moorman
et
al
vitro
studi
use
normal
human
lung
fibroblast
moorman
colleagu
found
hcv
core
protein
induc
mrna
protein
express
via
moorman
et
al
taken
togeth
studi
suggest
hcv
core
protein
interact
receptor
complement
system
contribut
pathogenesi
multipl
diseas
associ
hcv
infect
investig
proinflammatori
role
hcv
core
protein
may
provid
clearer
understand
pathogenesi
hcvassoci
diseas
chronic
hcv
infect
character
persist
complement
activ
lead
liver
fibrosi
despit
antivir
therapi
interbreed
fibrosissuscept
fibrosisresist
strain
mice
identifi
associ
hepat
fibrosi
small
molecul
inhibitor
receptor
antifibrot
effect
vivo
hillebrandt
et
al
polymorph
human
gene
associ
advanc
liver
fibrosi
compar
mild
fibrosi
chronic
hcv
infect
hillebrandt
et
al
fig
moreov
atrisk
haplotyp
human
associ
high
serum
level
hillebrandt
et
al
data
suggest
causal
role
nonhcv
hcvassoci
hepat
fibrosi
across
speci
therapeut
could
benefici
treatment
strategi
although
denv
inhibit
activ
complement
system
avirutnan
et
al
evid
suggest
complement
activ
may
contribut
increas
diseas
sever
follow
denv
infect
fig
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
seriou
clinic
condit
typic
occur
second
dengu
infect
differ
viral
serotyp
primari
infect
infant
born
dengueimmun
mother
lower
level
fb
higher
level
cleavag
product
detect
sever
ill
dhf
patient
correl
sign
shock
suggest
complement
activ
contribut
sever
form
dengu
virusinduc
diseas
bokisch
et
al
churdboonchart
et
al
nascimento
et
al
addit
dhf
patient
found
higher
level
fd
cleav
fb
yield
activ
convertas
lower
level
fh
inactiv
convertas
compar
patient
df
nascimento
et
al
studi
shown
plasma
level
product
complement
activ
includ
known
vascular
effect
termin
complement
complex
present
higher
level
dhf
patient
plasma
leakag
took
place
avirutnan
et
al
support
hypothesi
complement
activ
involv
develop
sever
diseas
comparison
global
gene
express
profil
peripher
blood
mononuclear
cell
pbmc
patient
df
dhf
discov
complement
inhibitor
strongli
upregul
pbmc
df
patient
pbmc
dhf
patient
furthermor
wildtyp
mbl
genotyp
mbl
genotyp
associ
reduc
mbl
level
associ
develop
denguerel
thrombocytopenia
sever
diseas
aciolisanto
et
al
interest
given
recent
find
mbl
bind
denv
result
complement
activ
viru
neutral
studi
implic
complement
system
pathogenesi
sever
form
dengu
viru
associ
diseas
dhfdss
howev
mechan
complement
system
contribut
diseas
sever
well
understood
arthritogen
alphavirus
includ
ross
river
viru
rrv
chikungunya
viru
mosquitoborn
virus
caus
debilit
musculoskelet
inflamm
pain
human
evid
complement
activ
detect
synovi
fluid
rrvinfect
patient
morrison
et
al
similarli
mous
model
rrvinduc
diseas
complement
activ
product
detect
inflam
joint
muscl
tissu
wildtyp
mice
morrison
et
al
rrvinfect
mice
exhibit
less
sever
destruct
skelet
muscl
tissu
less
sever
diseas
sign
indic
import
role
complement
rrv
pathogenesi
fig
mice
defici
also
develop
less
sever
tissu
damag
diseas
sign
follow
rrv
infect
morrison
et
al
fig
interestingli
neither
defici
prevent
recruit
inflammatori
leukocyt
musculoskelet
tissu
suggest
may
act
downstream
inflammatori
cell
invas
promot
tissu
damag
rrv
infect
morrison
et
al
morrison
et
al
genet
absenc
significantli
diminish
rrvinduc
express
within
inflam
skelet
muscl
tissu
indic
induct
regul
least
part
interact
ligand
morrison
et
al
furthermor
mice
defici
mbl
mbldko
also
develop
less
sever
rrvinduc
diseas
mice
reduc
mbl
deposit
tissu
unpublish
result
provid
evid
rrv
infect
lead
complement
activ
via
lectindepend
activ
pathway
taken
togeth
studi
suggest
interf
complement
cascad
andor
complement
receptor
signal
may
repres
use
rout
therapeut
intervent
rrvinduc
diseas
final
recent
evid
suggest
complement
system
may
contribut
seizur
induc
viru
infect
infect
wildtyp
mice
theiler
murin
encephalomyel
viru
tmev
result
acut
seizur
libbey
et
al
libbey
et
al
contrast
mice
develop
far
fewer
seizur
follow
tmev
infect
correl
reduc
number
activ
microglia
macrophag
hippocampu
dentat
gyru
well
decreas
neuron
cell
loss
libbey
et
al
fig
interestingli
deplet
system
complement
cobra
venom
factor
impact
tmevinduc
seizur
suggest
local
produc
complement
within
central
nervou
system
suffici
enhanc
tmevinduc
seizur
libbey
et
al
clear
complement
system
critic
determin
outcom
infect
varieti
differ
virus
understand
mechan
complement
protect
virusinduc
diseas
improv
dramat
research
area
continu
contribut
knowledg
viral
pathogenesi
continu
provid
insight
regul
immun
respons
lead
improv
therapeut
vaccin
approach
viral
nonvir
pathogen
perhap
less
well
understood
mechan
complement
function
pathogen
effector
virusinduc
diseas
progress
toward
identifi
signal
pathway
lead
complement
activ
understood
mani
virus
particularli
vivo
deeper
understand
impact
complement
activ
host
immun
respons
viral
infect
may
shed
light
exampl
recent
studi
identifi
critic
role
complement
system
regul
cell
lajoi
et
al
regul
myeloidderiv
suppressor
cell
markiewski
et
al
induct
autophagi
joubert
et
al
link
virusinduc
diseas
addit
complement
system
intric
link
pathway
play
import
role
viral
pathogenesi
tolllik
receptor
signal
network
coagul
system
markiewski
et
al
thu
continu
investig
role
complement
viral
pathogenesi
provid
import
insight
virushost
interact
strategi
prevent
treat
virusinduc
diseas
